Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Cardiometabolic risks of SARS-CoV-2 hospitalization using Mendelian Randomization

Submitted by Frida Mäkelä on Wed, 06/28/2023 - 13:25
  • Read more about Cardiometabolic risks of SARS-CoV-2 hospitalization using Mendelian Randomization

An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism

Submitted by Frida Mäkelä on Wed, 06/28/2023 - 11:01
  • Read more about An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism

Genetically proxied interleukin-6 receptor inhibition: opposing associations with COVID-19 and pneumonia

Submitted by Frida Mäkelä on Wed, 06/28/2023 - 10:57
  • Read more about Genetically proxied interleukin-6 receptor inhibition: opposing associations with COVID-19 and pneumonia

Causal associations between COVID-19 and atrial fibrillation: A bidirectional Mendelian randomization study

Submitted by Frida Mäkelä on Wed, 06/28/2023 - 10:52
  • Read more about Causal associations between COVID-19 and atrial fibrillation: A bidirectional Mendelian randomization study

Mendelian randomization analysis to characterize causal association between coronary artery disease and COVID-19

Submitted by Frida Mäkelä on Wed, 06/28/2023 - 10:45
  • Read more about Mendelian randomization analysis to characterize causal association between coronary artery disease and COVID-19

Body mass index and carpal tunnel syndrome: a Mendelian randomization study

Submitted by Frida Mäkelä on Wed, 06/28/2023 - 10:40
  • Read more about Body mass index and carpal tunnel syndrome: a Mendelian randomization study

Novel discoveries and enhanced genomic prediction from modelling genetic risk of cancer age-at-onset

Submitted by Frida Mäkelä on Wed, 06/28/2023 - 10:03
  • Read more about Novel discoveries and enhanced genomic prediction from modelling genetic risk of cancer age-at-onset

Neurogenetic and multi-omic sources of overlap among sensation seeking, alcohol consumption, and alcohol use disorder

Submitted by Frida Mäkelä on Wed, 06/28/2023 - 10:00
  • Read more about Neurogenetic and multi-omic sources of overlap among sensation seeking, alcohol consumption, and alcohol use disorder

Systematic disease-agnostic identification of therapeutically actionable targets using the genetics of human plasma proteins

Submitted by Frida Mäkelä on Wed, 06/28/2023 - 09:55
  • Read more about Systematic disease-agnostic identification of therapeutically actionable targets using the genetics of human plasma proteins

The Genetics of Idiopathic Intracranial Hypertension (IIH): Integration of Population Studies and Clinical Data

Submitted by Frida Mäkelä on Wed, 06/28/2023 - 09:53
  • Read more about The Genetics of Idiopathic Intracranial Hypertension (IIH): Integration of Population Studies and Clinical Data

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 387
  • Page 388
  • Page 389
  • Page 390
  • Current page 391
  • Page 392
  • Page 393
  • Page 394
  • Page 395
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement